Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTTP | P55157 | 15/20 | 0.48 |
| ▸ | FLT1 | P17948 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | FLT3 | P36888 | 2/20 | 0.43 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | APOB | P04114 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6673495 | 0.89 | MTTP (0.49) | MTTPGAAAPOB | |
| SCHEMBL7038654 | 0.89 | MTTP (0.51) | MTTPGAAAPOB | |
| SCHEMBL6675701 | 0.88 | MTTP (0.46) | MTTPGAABDKRB1APOB | |
| SCHEMBL6674378 | 0.85 | MTTP (0.44) | MTTPGAABDKRB1APOB | |
| SCHEMBL7041617 | 0.82 | MTTP (0.52) | MTTPGAAALDH1A1APOB | |
| SCHEMBL6672977 | 0.80 | P2RY14 (0.43) | MTTPGAAAPOB | |
| SCHEMBL6674749 | 0.79 | MTTP (0.44) | MTTPGAAAPOB | |
| SCHEMBL6674626 | 0.79 | MTTP (0.43) | MTTPGAABDKRB1ALDH1A1HPGD | |
| SCHEMBL6673563 | 0.79 | MTTP (0.47) | MTTPALDH1A1HPGDKMT2AAPOB | |
| SCHEMBL7109972 | 0.78 | MTTP (0.50) | MTTPGAAAPOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1465613-A2 | COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS | Boehringer Ingelheim Pharma GmbH & Co. KG (DE) | 2004-10-13 | — | — | EP | disclosed |
| WO-2003057205-A2 | COMBINATION OF MTP INHIBITORS OR APOB SECRETION INHIBITORS WITH FIBRATES FOR USE AS DRUGS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2003-07-17 | — | — | WO | disclosed |